Hepatic Impairment Completed Phase 1 Trials for Fimasartan (DB09279)

Also known as: Liver impairment / Diseases of liver (K70-K77) / Hepatic pathology / Fector hepaticus / [X]Diseases of the liver / Hepatopathy / Hepatic disease NOS / Hepatic disorder (NOS) / Disorder hepatic / Hepatic disorder NOS / Disease hepatocellular / Disorder liver / Hepatic disease / Hepatic disease (NOS) / Liver disorder / Liver Diseases / Unspecified disorder of liver

IndicationStatusPhase
DBCOND0031585 (Hepatic Impairment)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01146938A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers